These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 17667131

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C, Franco-Vidal V, Bebear JP, Darrouzet V.
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Endolymphatic sac decompression as a treatment for Meniere's disease.
    Durland WF, Pyle GM, Connor NP.
    Laryngoscope; 2005 Aug; 115(8):1454-7. PubMed ID: 16094123
    [Abstract] [Full Text] [Related]

  • 6. Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy.
    Ozakbas S, Akdede BB, Kösehasanogullari G, Aksan O, Idiman E.
    J Neurol Sci; 2007 May 15; 256(1-2):30-4. PubMed ID: 17379247
    [Abstract] [Full Text] [Related]

  • 7. The reliability and validity of the Vertigo Symptom Scale and the Vertigo Dizziness Imbalance Questionnaires in a Turkish patient population with benign paroxysmal positional vertigo.
    Yanik B, Külcü DG, Kurtais Y, Boynukalin S, Kurtarah H, Gökmen D.
    J Vestib Res; 2008 May 15; 18(2-3):159-70. PubMed ID: 19126986
    [Abstract] [Full Text] [Related]

  • 8. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N.
    Laryngoscope; 2007 Aug 15; 117(8):1474-81. PubMed ID: 17607149
    [Abstract] [Full Text] [Related]

  • 9. What is the effect of dizziness on the quality of life for patients with Meniere's disease?
    Cunha F, Settanni FA, Ganança FF.
    Rev Laryngol Otol Rhinol (Bord); 2005 Aug 15; 126(3):155-8. PubMed ID: 16366382
    [Abstract] [Full Text] [Related]

  • 10. People with symptoms of Ménière's disease: the relationship between illness intrusiveness, illness uncertainty, dizziness handicap, and depression.
    Arroll M, Dancey CP, Attree EA, Smith S, James T.
    Otol Neurotol; 2012 Jul 15; 33(5):816-23. PubMed ID: 22705835
    [Abstract] [Full Text] [Related]

  • 11. Clinimetrics of Meniere's disease.
    Gates GA.
    Laryngoscope; 2000 Mar 15; 110(3 Pt 3):8-11. PubMed ID: 10718407
    [Abstract] [Full Text] [Related]

  • 12. Quality-of-life assessment of Ménière's disease patients after surgical labyrinthectomy.
    Diaz RC, LaRouere MJ, Bojrab DI, Zappia JJ, Sargent EW, Shaia WT.
    Otol Neurotol; 2007 Jan 15; 28(1):74-86. PubMed ID: 16985479
    [Abstract] [Full Text] [Related]

  • 13. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.
    Gates GA, Green JD, Tucci DL, Telian SA.
    Arch Otolaryngol Head Neck Surg; 2004 Jun 15; 130(6):718-25. PubMed ID: 15210552
    [Abstract] [Full Text] [Related]

  • 14. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière's disease--a clinical multicentre placebo-controlled study.
    Odkvist LM, Arlinger S, Billermark E, Densert B, Lindholm S, Wallqvist J.
    Acta Otolaryngol Suppl; 2000 Jun 15; 543():99-101. PubMed ID: 10908991
    [Abstract] [Full Text] [Related]

  • 15. Intratympanic gentamicin for Ménière's disease: effect on quality of life as assessed by Glasgow benefit inventory.
    Banerjee AS, Johnson IJ.
    J Laryngol Otol; 2006 Oct 15; 120(10):827-31. PubMed ID: 16707038
    [Abstract] [Full Text] [Related]

  • 16. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK, Sandooram D, Prinsley PR.
    J Laryngol Otol; 2006 Sep 15; 120(9):730-5. PubMed ID: 16848921
    [Abstract] [Full Text] [Related]

  • 17. The relevance of an elevation in the plasma vasopressin levels to the pathogenesis of Meniere's attack.
    Aoki M, Asai M, Nishihori T, Mizuta K, Ito Y, Ando K.
    J Neuroendocrinol; 2007 Nov 15; 19(11):901-6. PubMed ID: 17927668
    [Abstract] [Full Text] [Related]

  • 18. Cognitions associated with anxiety in Ménière's disease.
    Kirby SE, Yardley L.
    J Psychosom Res; 2009 Feb 15; 66(2):111-8. PubMed ID: 19154853
    [Abstract] [Full Text] [Related]

  • 19. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA, Couthino De Toledo H, Hinojosa-González R, Pane-Pianese C, Ríos-Castañeda LC.
    Otolaryngol Head Neck Surg; 2005 Aug 15; 133(2):285-94. PubMed ID: 16087029
    [Abstract] [Full Text] [Related]

  • 20. Intractable benign paroxysmal positional vertigo in patients with Meniere's disease.
    Gross EM, Ress BD, Viirre ES, Nelson JR, Harris JP.
    Laryngoscope; 2000 Apr 15; 110(4):655-9. PubMed ID: 10764014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.